专利检索 ap:("Schering Corporation" OR "PHARMACOPEIA, INC.") AND inv:"MERRITT, Robert, J." 第 1 页

1.

发明公开
3,4-DI-SUBSTITUTED PYRIDAZINEDIONES AS CXC CHEMOKINE RECEPTOR ANTAGONISTS 审中-公开
标题翻译： 3,4-二取代PYRIDAZINDIONEN AS CXC趋化因子受体拮抗剂

公开(公告)号：EP1461321A1

公开(公告)日：2004-09-29

申请号：EP03705667.8

申请日：2003-01-03

申请人： Schering Corporation , PHARMACOPEIA, INC.

发明人： TAVERAS, Arthur, G. , DWYER, Michael , CHAO, Jianping , BALDWIN, John, J. , MERRITT, Robert, J. , LI, Ge , CHAO, Jianhua , YU, Younong

IPC分类号： C07D237/22 , C07D409/12 , C07D405/12 , C07D417/12 , C07D403/12 , A61K31/501 , A61P35/00

CPC分类号： C07D403/12 , C07D237/22 , C07D405/12 , C07D409/12 , C07D417/12

摘要： Disclosed compounds of the formula (I) or a pharmaceutically acceptable salt or solvate thereof. The compounds are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.